Os. Opgaard et al., LOCALIZATION OF ENDOTHELIN IMMUNOREACTIVITY AND DEMONSTRATION OF CONSTRICTORY ENDOTHELIN-A RECEPTORS IN HUMAN CORONARY-ARTERIES AND VEINS, Journal of cardiovascular pharmacology, 23(4), 1994, pp. 576-583
Strong immunoreactivity for endothelins (ETs) was observed in the endo
thelium of both human epicardial coronary arteries and veins. The cont
ractile responses to ET-1, ET-2, and ET-3 were investigated in isolate
d circular human coronary vessel segments. ET-1, ET-2, and ET-3 induce
d significantly higher maximum contraction (measured in percentage of
contraction induced by 60 mM potassium) and more potent responses in v
eins as compared with arteries. ET-1 as compared with ET-2 induced equ
al maximum contraction and equipotent responses both when tested in ar
teries and veins, whereas ET-3 induced lower maximum contraction and l
ess potent responses in both vessel types. FR 139317, a selective ET(A
) receptor antagonist, significantly decreased the potency of ET-1 and
ET-2 responses in both human coronary arteries and veins, but the max
imum effect obtained did not change significantly. The existence of ET
immunoreactivity (IR) in endothelial cells from both human coronary a
rteries and veins indicates that ETs may be released endogenously. The
effect of the selective ET(A) receptor antagonist FR 139317 indicates
that the contraction induced by ET-1 and ET-2 in both arteries and ve
ins is mediated by ET(A) receptors.